|
|
|
|
Science Sparks @ ACTREC
|
 10th February 2025 |
Vol. No. 14 ; Issue No.669 |
|
|
Publications
|
|
1. Mojidra R, Gardi N, Bagal B, Khattry N, Gokarn A, Punatar S, Govekar R (2025). Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia. Advances in Biomarker Sciences and Technology
2. Agrawal N, Govekar R (2025). Incremental modification in the existing approaches for affinity chromatographic enrichment of phosphoproteins improves their profile in liquid chromatography-tandem mass spectrometry analysis. Analytical Science Advances. 6(1):e202400058.
3. Joshi P, Kole L, Patil A, Singh A, Shetty R, Nair S, Chaturvedi P (2025). A retrospective study of lip carcinoma at a tertiary cancer centre. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
4. Dinesan A, Singh M, Mehta P, Maitre P, Murthy V (2025). Acute enteritis with pelvic SBRT: Influence of bowel delineation methods. Clinical and Translational Radiation Oncology.
5. Sawant V, Mithun S, Jha AK, Rangarajan V (2025). Monte carlo simulation of characteristics of discovery NM/CT 670 pro SPECT system for routinely used diagnostic and therapeutic radionuclides. Journal of Nuclear Medicine Technology.
6. Dwivedi P, Barage S, Jha AK, Choudhury S, Rangarajan V (2025). Robustness of 18F-FDG PET radiomic features in lung cancer: Impact of advanced reconstruction algorithm. Journal of Nuclear Medicine Technology.
7. Gupta SK, Yadav S, Sharma D, Sandur SK, Khattry N, Goda JS, Gota V(2025). Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation. Journal of Ayurveda and Integrative Medicine. 16(2):101109
8. Bajpai J, Sarkar L, Rath S, Pawar A, Chandrashekharan A, Panda G, Jakar D, Ghosh J, Laskar S, Rekhi B, Khanna N, Jose J, Ramdawar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Prognostic modeling for bone sarcomas based on a large prospective cohort from a tertiary care cancer center in India. JCO Global Oncology.
9. Cortes J, Kim D-W, Saikia T, Khattry N, Rathnam K, Alvarado Y, Hannah G, Tantravahi S, Apperley J, Charbonnier A, García-Gutiérrez V, Lucchesi A, Dima D, Illés Á, Popav V, Abruzzese E, Nag A, Apte S, Badar T, Yao S-L, Saxena U, Sreenivasan J, Inamdar S, Chimote G, Nicolini F (2025). Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial. Lancet Haematology.
|
|
|
|
|
|
|
Video of the Week
|
|
| Harnessing AI Foundation Models for Cancer Diagnostics |
|
| |
|
|
| |
|
|
Upcoming Events
|
| |
|
7th Indian Cancer Genetics Conference & Workshop (ICGCW 2025)
|
|
22-23 February 2025
|
|
ICGC2025 Conference (Choksi Auditorium, TMH): 22-23 Feb 2025
Pre-conference NGS Hands on Workshop at ACTREC Navi Mumbai: 20-21st February 2025
Pre-conference Genetic Counselling (GC) Workshop at TMH, Mumbai: 20-21st February 2025.
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
Do You Know?
In 2011, The identification of abundant long noncoding RNAs (lncRNAs) in humans catalyzed the characterization of their role in cancer.
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
